APH.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:35):

Stats
Šios dienos apimtis	237 540
Vidutinė apimtis	1.02M
Rinkos kapitalizacija	188.87M
EPS	£0 ( 2024-04-09 )
Last Dividend	£1.184 ( 2023-06-22 )
Next Dividend	£0 ( N/A )
P/E	-34.95
ATR14	£0.108 (0.31%)

Tūris Koreliacija

Ilgas: 0.09 (neutral)

Trumpas: 0.07 (neutral)

Signal:(55.851) Neutral

Alliance Pharma PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RCN.L	0.919
XUEB.L	0.905
BIRG.L	0.905
AIBG.L	0.902
FOG.L	0.896
EBQ.L	0.885
NUM.L	0.883
DTY.L	0.881
EMAU.L	0.871
CLIN.L	0.867

10 Labiausiai neigiamai susiję koreliacijos
TEP.L	-0.906
3NIS.L	-0.896
LNGA.L	-0.885
GFIN.L	-0.884
INHC.L	-0.882
PTRO.L	-0.882
GIF.L	-0.882
BIDS.L	-0.878
ECHO.L	-0.872
PUR.L	-0.871

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Alliance Pharma PLC Koreliacija - Valiuta/Žaliavos

0.10
( neutral )

0.22
( neutral )

0.00
( neutral )

0.11
( neutral )

-0.03
( neutral )

-0.35
( neutral )

Alliance Pharma PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£167.42M
Bruto pelnas:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2022
Pajamos:	£167.42M
Bruto pelnas:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2021
Pajamos:	£163.21M
Bruto pelnas:	£109.45M (67.06 %)
EPS:	£0.0137

FY	2020
Pajamos:	£129.80M
Bruto pelnas:	£82.82M (63.80 %)
EPS:	£0.0154

Financial Reports:

No articles found.

Alliance Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0.592 (N/A)	£0 (N/A)	£1.184 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Alliance Pharma PLC Dividend Information - Dividend Junior

Dividend Sustainability Score: 6.61 - average (87.25%) | Divividend Growth Potential Score: 1.428 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.0700	2009-12-02
Last Dividend	£1.184	2023-06-22
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	£15.63	--
Avg. Dividend % Per Year	1.27%	--
Score	2.99	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	1.428
Div. Directional Score	4.02	--

Next Divdend (Est)
(2024-10-14)

£1.255 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

2.99

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2009	£0.0700	2.33%
2010	£0.400	1.48%
2011	£0.650	2.11%
2012	£0.775	2.51%
2013	£0.853	2.67%
2014	£0.938	2.32%
2015	£1.033	2.79%
2016	£1.137	2.65%
2017	£1.250	2.75%
2018	£1.375	2.04%
2019	£1.513	2.30%
2020	£0.536	0.63%
2021	£2.20	2.50%
2022	£1.720	1.57%
2023	£1.184	2.17%
2024	£0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RHIM.L	Dividend Knight	2023-08-24	Annually	7	3.49%
HAT.L	Dividend Knight	2023-09-07	Semi-Annually	18	2.55%
ASL.L	Dividend Knight	2023-08-03	Semi-Annually	34	1.34%
UKCM.L	Dividend King	2023-08-17	Quarterly	18	2.99%
MIG5.L	Dividend Knight	2023-06-22	Semi-Annually	24	4.45%
D4T4.L	Dividend Knight	2023-07-20	Semi-Annually	27	1.32%
SEIT.L	Dividend Knight	2023-09-14	Quarterly	6	3.23%
IBST.L	Dividend Knight	2023-08-24	Annually	9	2.72%
BILN.L	Dividend Knight	2023-06-08	Sporadic	29	1.95%
WSP.L	Dividend Knight	2023-06-29	Semi-Annually	30	1.95%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0415	1.500	-0.830	-1.245	[0 - 0.5]
returnOnAssetsTTM	-0.0137	1.200	-0.458	-0.550	[0 - 0.3]
returnOnEquityTTM	-0.0250	1.500	-1.389	-2.08	[0.1 - 1]
payoutRatioTTM	-1.315	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.931	0.800	5.35	4.28	[1 - 3]
quickRatioTTM	1.333	0.800	6.86	5.49	[0.8 - 2.5]
cashRatioTTM	0.533	1.500	8.15	10.00	[0.2 - 2]
debtRatioTTM	0.242	-1.500	5.96	-8.94	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0397	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.449	-1.500	8.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.516	1.000	4.74	4.74	[0.2 - 0.8]
operatingProfitMarginTTM	0.144	1.000	9.13	9.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.143	-0.143	[0.2 - 2]
assetTurnoverTTM	0.331	0.800	-1.127	-0.901	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-26.74	1.000	-2.80	0	[1 - 100]
returnOnEquityTTM	-0.0250	2.50	-0.893	-2.08	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0397	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	3.39	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	-1.315	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-50.54	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.31	0	[0.1 - 0.5]
Total Score				1.428

Alliance Pharma PLC

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.